Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Koch

Showing results (41-50 of 115) with videos related to

Pageof 12
Sort By:
BMC Cancer|July 31, 2012
AB0 blood group and prognosis in patients with pancreatic cancerNuh N Rahbari, Ulrich Bork, Ulf Hinz, et al.
Surgery|January 21, 2011
Ischemic colitis: who will survive?Christoph Reissfelder, Hussein Sweiti, Dalibor Antolovic, et al.
Annals of Surgery|January 15, 2005
Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastasesMoritz Koch, Peter Kienle, Ulf Hinz, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 16, 2008
Portal triad clamping versus vascular exclusion for vascular control during hepatic resection: a systematic review and meta-analysisNuh N Rahbari, Moritz Koch, Arianeb Mehrabi, et al.
BMC Surgery|March 5, 2011
A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007)Dalibor Antolovic, Christoph Reissfelder, Anastasia Rakow, et al.
International Journal of Cancer|January 21, 2006
Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancerMoritz Koch, Peter Kienle, Dorejd Kastrati, et al.
Annals of Surgical Oncology|May 21, 2011
Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastasesNuh N Rahbari, Christoph Reissfelder, Monika Mühlbayer, et al.
Annals of Surgical Oncology|September 5, 2013
Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trialsNuh N Rahbari, Heike Elbers, Vasileios Askoxylakis, et al.
Frontiers in Bioengineering and Biotechnology|September 1, 2022
The survivor strain: isolation and characterization of <i>Phormidium yuhuli</i> AB48, a filamentous phototactic cyanobacterium with biotechnological potentialMoritz Koch, Avery J C Noonan, Yilin Qiu, et al.
Frontiers in Bioengineering and Biotechnology|March 31, 2023
Corrigendum: The survivor strain: Isolation and characterization of <i>Phormidium yuhuli</i> AB48, a filamentous phototactic cyanobacterium with biotechnological potentialMoritz Koch, Avery J C Noonan, Yilin Qiu, et al.
Pageof 12

Showing results (41-50 of 115) with videos related to

Sort By:
Pageof 12
BMC Cancer|July 31, 2012
AB0 blood group and prognosis in patients with pancreatic cancerNuh N Rahbari, Ulrich Bork, Ulf Hinz, et al.
Surgery|January 21, 2011
Ischemic colitis: who will survive?Christoph Reissfelder, Hussein Sweiti, Dalibor Antolovic, et al.
Annals of Surgery|January 15, 2005
Detection of hematogenous tumor cell dissemination predicts tumor relapse in patients undergoing surgical resection of colorectal liver metastasesMoritz Koch, Peter Kienle, Ulf Hinz, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|July 16, 2008
Portal triad clamping versus vascular exclusion for vascular control during hepatic resection: a systematic review and meta-analysisNuh N Rahbari, Moritz Koch, Arianeb Mehrabi, et al.
BMC Surgery|March 5, 2011
A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007)Dalibor Antolovic, Christoph Reissfelder, Anastasia Rakow, et al.
International Journal of Cancer|January 21, 2006
Prognostic impact of hematogenous tumor cell dissemination in patients with stage II colorectal cancerMoritz Koch, Peter Kienle, Dorejd Kastrati, et al.
Annals of Surgical Oncology|May 21, 2011
Correlation of circulating angiogenic factors with circulating tumor cells and disease recurrence in patients undergoing curative resection for colorectal liver metastasesNuh N Rahbari, Christoph Reissfelder, Monika Mühlbayer, et al.
Annals of Surgical Oncology|September 5, 2013
Neoadjuvant radiotherapy for rectal cancer: meta-analysis of randomized controlled trialsNuh N Rahbari, Heike Elbers, Vasileios Askoxylakis, et al.
Frontiers in Bioengineering and Biotechnology|September 1, 2022
The survivor strain: isolation and characterization of <i>Phormidium yuhuli</i> AB48, a filamentous phototactic cyanobacterium with biotechnological potentialMoritz Koch, Avery J C Noonan, Yilin Qiu, et al.
Frontiers in Bioengineering and Biotechnology|March 31, 2023
Corrigendum: The survivor strain: Isolation and characterization of <i>Phormidium yuhuli</i> AB48, a filamentous phototactic cyanobacterium with biotechnological potentialMoritz Koch, Avery J C Noonan, Yilin Qiu, et al.
Pageof 12